pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

ViaCyte, Inc., a leader in the emerging field of regenerative medicine, is a private, venture-capital backed company headquartered in San Diego, California focused on profoundly improving the way patients with diabetes are treated.

LOCATION

  • San Diego, CA, USA

    • THERAPEUTIC AREAS

  • Metabolic Disorders

  • Regenerative Medicine

    • WEBSITE

    https://viacyte.com/

    CAREER WEBSITE

    https://viacyte.com/careers

    SOCIAL MEDIA

    INVESTORS

    asset-management bd-ventures hospira jjdc portage-venture-partners ra-capital sanderling-ventures the-clayton-foundation

    PRESS RELEASES


    Jul 11, 2022

    Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative VX-880 Programs in Type 1 Diabetes


    Apr 20, 2022

    ViaCyte to Participate in 2022 Advanced Technologies and Treatments for Diabetes Conference


    Jan 19, 2022

    ViaCyte Strengthens Management Team with Appointment of Alyssa Levin as Chief Financial Officer and Addition of Lisa Porter, MD, to the Board of Directors


    Dec 3, 2021

    ViaCyte Chief Scientific Officer to Deliver Keynote Address at JDRF Mission Summit


    Dec 2, 2021

    ViaCyte's Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies


    For More Press Releases
    Google Analytics Alternative